DSM-Firmenich AG (DSFIR) | Stock Overview & Key Data
DSM-Firmenich AG | Large-cap | Basic Materials
DSM-Firmenich AG | Large-cap | Basic Materials
DSM-Firmenich AG Performance Comparison
Stock Range
Today's Range
Low: €72.96
High: €74.40
on September 23, 2025
52 Week Range
Low: €72.96
High: €124.85
on September 23, 2025
on October 1, 2024
All-Time High: €124.85 on September 30, 2024
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Market Cap
€20.0B
EPS
2.72
P/E Ratio (TTM)
27.46
Forward P/E
24.65
P/B Ratio
0.92
PEG Ratio
24.65
Div. Yield
2.63%
ROE
3.52%
Beta
1.004
Debt to Equity
25.24
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
12.07%
Profit Margin
5.52%
Returns and Earnings
Return on Assets (TTM)
2.18%
Return on Equity (TTM)
3.52%
EBITDA
€1.7B
Net Income (TTM)
€718.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€49.05
Quarterly Revenue Growth (YoY)
3.40%
Quarterly Earnings Growth (YoY)
1,114.30%
Dividend Information
Last 12-Month Dividend
€2.50
Current Dividend Yield
2.63%
3-Year Average Dividend Yield
2.22%
3-Year Average Annual Dividend
€2.20
3-Year Total Dividends
€6.60
Ex-Dividend Date
May 8, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| DSM-Firmenich AG DSFIR | 19.96B Large-cap | -6.72% | -13.02% | -22.47% | -20.37% | -24.77% | -40.12% | -39.12% | -39.12% |
| Akzo Nobel N.V AKZA | 10.45B Large-cap | 1.91% | 2.61% | 7.19% | 4.31% | 8.88% | -3.70% | 6.34% | -30.31% |
| IMCD N.V IMCD | 5.48B Large-cap | 1.33% | -2.09% | -16.70% | -27.61% | -34.83% | -41.24% | -24.27% | -10.34% |
| OCI N.V OCI | 900.71M Mid-cap | -12.86% | -14.08% | -43.67% | -60.93% | -61.64% | -83.36% | -88.63% | -63.00% |
| Corbion N.V CRBN | 1.00B Large-cap | 1.54% | -2.61% | -6.48% | -14.92% | -21.09% | -33.66% | -33.09% | -58.82% |
| Avantium N.V AVTX | 107.58M Small-cap | -14.17% | -44.16% | -42.32% | -47.48% | -60.05% | -61.61% | -72.42% | -84.75% |
Ownership & Short Interest
Insider Ownership
9.64%
Institutional Ownership
32.23%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
812K
Average 90-Day Volume
526K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DSFIR's 52-week high and low?
- In the last 52 weeks, DSM-Firmenich AG reached a high of €124.85 (on October 1, 2024) and a low of €72.96 (on September 23, 2025).
- What is the market cap and P/E ratio for DSFIR?
- Curious about DSM-Firmenich AG's size and valuation? Its market capitalization stands at 19.96B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.46, and the forward P/E (looking ahead) is 24.65.
- Does DSFIR pay dividends? If so, what's the yield?
- Yes, DSM-Firmenich AG is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.63%, and the company has paid an average of €2.20 per share annually over the past 3 years.
- Who are DSM-Firmenich AG's main competitors or similar companies to consider before investing?
When looking at DSM-Firmenich AG, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Akzo Nobel N.V
AKZA10.45B Basic Materials Specialty Chemicals -3.70% 6.34% IMCD N.V
IMCD5.48B Basic Materials Specialty Chemicals -41.24% -24.27% OCI N.V
OCI900.71M Basic Materials Specialty Chemicals -83.36% -88.63% Corbion N.V
CRBN1.00B Basic Materials Specialty Chemicals -33.66% -33.09% Avantium N.V
AVTX107.58M Basic Materials Specialty Chemicals -61.61% -72.42% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for DSM-Firmenich AG? (e.g., ROE, Debt/Equity)
- To get a sense of DSM-Firmenich AG's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.52%, the Debt to Equity ratio from the most recent quarter is 25.24, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for DSFIR?
- Looking at DSM-Firmenich AG's growth, its revenue over the trailing twelve months (TTM) was €13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.40%, and quarterly earnings saw a YoY growth of 1,114.30%.
- How much of DSFIR stock is held by insiders and institutions?
- Wondering who owns DSM-Firmenich AG stock? Company insiders (like executives and directors) hold about 9.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 32.23%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.